Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

Clinical trial NCT00325078 · TERMINATED

Trial details

NCT number: NCT00325078
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Granulomatous Disease Crohn'S-like IBD Inflammatory Bowel Disease (IBD)

Start date: 2006-05-01
Primary completion: 2012-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.